Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01781806 · ClinicalTrials.gov registry record · Phase 4
A Demonstration Project to Add Pre- or Post-exposure Prophylaxis to Combination HIV Prevention Services
A Phase 4 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 4
- Development phase
- 328
- Enrollment target
NCT01781806: Completed Phase 4 study, sponsored by University of California, Los Angeles.
NCT01781806 is a Phase 4 study that has completed, run by University of California, Los Angeles. The registered enrollment target is 328 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (37% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01781806, a Phase 4 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 328 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety, acceptability and feasibility of delivery of Pre-Exposure Prophylaxis (PrEP) or Post-Exposure Prophylaxis) PEP as part of combination HIV prevention services for high-risk MSM and transgender women.
Primary Outcome
Number and frequency rate of clinical and laboratory AEs (Gr 2 and above), including SAEs by Cohort.
Interventions
- DRUG emtricitabine 200mg/tenofovir 300mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 328 participants |
| Start Date | 2013-05 |
| Est. Completion | 2016-05 |
| Phase | Phase 4 |
What the finished NCT01781806 record still lists
NCT01781806 is an interventional study that assigns participants to a tested intervention. The registered 328 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (37% lower).
The record links to 0 conditions, and to 1 intervention - of which emtricitabine 200mg/tenofovir 300mg is the first listed.
NCT01781806 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01781806 about?
NCT01781806 is a clinical study titled "A Demonstration Project to Add Pre- or Post-exposure Prophylaxis to Combination HIV Prevention Services". The purpose of this study is to evaluate the safety, acceptability and feasibility of delivery of Pre-Exposure Prophylaxis (PrEP) or Post-Exposure Prophylaxis) PEP as part of combination HIV prevention services for high-risk MSM and transgender women.
What is the current status of trial NCT01781806?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 328 participants. The study started on 2013-05. Estimated completion is 2016-05.
What interventions are being tested in trial NCT01781806?
The interventions under investigation include: emtricitabine 200mg/tenofovir 300mg (DRUG).
Who is sponsoring clinical trial NCT01781806?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01781806's enrollment target sits among peer trials
328 253rd of 2000 higher than 1,748 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05156983 · 328 participants · Phase 3
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
- NCT05380401 · 328 participants · NA
Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants
- NCT05548413 · 328 participants · NA
Improving Medication Adherence Using Family-focused and Literacy-sensitive Strategies
- NCT06393725 · 328 participants · NA
Synchronous vs Asynchronous Remotely Delivered Lifestyle Interventions
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia